HEADER TRANSLATION 21-SEP-23 8QM5 TITLE POTENTIAL DRUG BINDING SITES FOR TRANSLATION INITIATION FACTOR EIF4E COMPND MOL_ID: 1; COMPND 2 MOLECULE: EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EIF4E; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS (DE3)-RIPL KEYWDS TRANSLATION INITIATION FACTOR, TRANSLATION REGULATOR, PROTEIN KEYWDS 2 BIOSYNTHESIS, RNA BINDING, TRANSLATION EXPDTA X-RAY DIFFRACTION AUTHOR A.CLEASBY REVDAT 1 15-JAN-25 8QM5 0 JRNL AUTH Y.S.SHARP,M.MARTELLA,C.I.MILTON,G.WARD,A.J.WOODHEAD, JRNL AUTH 2 C.J.RICHARDSON,M.G.CARR,E.CHIARPARIN,B.D.CONS,J.COYLE, JRNL AUTH 3 S.D'AGOSTINO,C.E.EAST,S.D.HISCOCK,C.MARTINEZ-FLEITES, JRNL AUTH 4 P.N.MORTENSON,N.PALMER,P.PATHURI,M.V.POWERS,S.M.SAALAU, JRNL AUTH 5 J.D.ST.DENIS,K.SWABEY,M.VINKOVIC,G.WILLIAMS,P.A.CLARKE JRNL TITL INTEGRATING FRAGMENT-BASED SCREENING WITH TARGETED PROTEIN JRNL TITL 2 DEGRADATION AND GENETIC RESCUE TO EXPLORE EIF4E FUNCTION JRNL REF NAT COMMUN 2025 JRNL REFN ESSN 2041-1723 JRNL DOI 10.1038/S41467-024-54356-1 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (16-JUL-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 32050 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1584 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.69 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 641 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2906 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 595 REMARK 3 BIN R VALUE (WORKING SET) : 0.2895 REMARK 3 BIN FREE R VALUE : 0.3062 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.18 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3327 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.45890 REMARK 3 B22 (A**2) : 3.22530 REMARK 3 B33 (A**2) : 5.23370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.60980 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.165 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.138 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.331 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.139 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6796 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 12218 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1495 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1091 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6796 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 426 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5038 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 6.76 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.75 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|11 - A|217 } REMARK 3 ORIGIN FOR THE GROUP (A): 20.7378 -13.6616 4.5713 REMARK 3 T TENSOR REMARK 3 T11: -0.0182 T22: -0.0358 REMARK 3 T33: 0.0087 T12: -0.0119 REMARK 3 T13: 0.0284 T23: -0.0066 REMARK 3 L TENSOR REMARK 3 L11: 1.5400 L22: 0.8848 REMARK 3 L33: 1.0651 L12: 0.0447 REMARK 3 L13: 0.3033 L23: -0.7409 REMARK 3 S TENSOR REMARK 3 S11: 0.0267 S12: -0.0746 S13: 0.1560 REMARK 3 S21: 0.0112 S22: -0.0534 S23: -0.1187 REMARK 3 S31: 0.0623 S32: -0.0824 S33: 0.0267 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|9 - B|217 } REMARK 3 ORIGIN FOR THE GROUP (A): 1.5714 -21.6371 31.7680 REMARK 3 T TENSOR REMARK 3 T11: 0.0849 T22: -0.0482 REMARK 3 T33: -0.0598 T12: 0.0072 REMARK 3 T13: 0.0886 T23: 0.0166 REMARK 3 L TENSOR REMARK 3 L11: 0.8240 L22: 0.3504 REMARK 3 L33: 1.4013 L12: -0.0153 REMARK 3 L13: -0.2355 L23: 0.0287 REMARK 3 S TENSOR REMARK 3 S11: -0.0809 S12: -0.0249 S13: -0.1087 REMARK 3 S21: 0.0648 S22: 0.0003 S23: 0.1092 REMARK 3 S31: -0.0258 S32: 0.0714 S33: 0.0806 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS WERE FULLY REFINED REMARK 3 WITH FULL OCCUPANCY AT NUCLEAR POSITION. REMARK 4 REMARK 4 8QM5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1292133481. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32579 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.889 REMARK 200 RESOLUTION RANGE LOW (A) : 38.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.002M DTT 40% PEG 400 0.1M PH=7.5 REMARK 280 HEPES/NAOH, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.43850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 GLY A 10 REMARK 465 MET B 3 REMARK 465 HIS B 4 REMARK 465 HIS B 5 REMARK 465 HIS B 6 REMARK 465 HIS B 7 REMARK 465 HIS B 8 REMARK 465 GLY B 26 REMARK 465 GLY B 27 REMARK 465 GLY B 28 REMARK 465 GLU B 29 REMARK 465 ASN B 30 REMARK 465 LEU B 31 REMARK 465 TYR B 32 REMARK 465 PHE B 33 REMARK 465 GLN B 34 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 50 50.94 -90.08 REMARK 500 ASP A 67 20.09 -144.42 REMARK 500 LYS A 119 -50.66 -29.28 REMARK 500 ASP A 143 -129.53 54.14 REMARK 500 ASP B 67 26.73 -143.24 REMARK 500 CYS B 89 27.05 -140.59 REMARK 500 LYS B 119 -69.32 17.47 REMARK 500 ASP B 143 -142.22 60.45 REMARK 500 REMARK 500 REMARK: NULL DBREF 8QM5 A 36 217 UNP P06730 IF4E_HUMAN 36 217 DBREF 8QM5 B 36 217 UNP P06730 IF4E_HUMAN 36 217 SEQADV 8QM5 MET A 3 UNP P06730 INITIATING METHIONINE SEQADV 8QM5 HIS A 4 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS A 5 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS A 6 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS A 7 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS A 8 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS A 9 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY A 10 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ALA A 11 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ARG A 12 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ILE A 13 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ILE A 14 UNP P06730 EXPRESSION TAG SEQADV 8QM5 TYR A 15 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ASP A 16 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ARG A 17 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ALA A 18 UNP P06730 EXPRESSION TAG SEQADV 8QM5 PHE A 19 UNP P06730 EXPRESSION TAG SEQADV 8QM5 LEU A 20 UNP P06730 EXPRESSION TAG SEQADV 8QM5 MET A 21 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ALA A 22 UNP P06730 EXPRESSION TAG SEQADV 8QM5 CYS A 23 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ARG A 24 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY A 25 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY A 26 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY A 27 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY A 28 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLU A 29 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ASN A 30 UNP P06730 EXPRESSION TAG SEQADV 8QM5 LEU A 31 UNP P06730 EXPRESSION TAG SEQADV 8QM5 TYR A 32 UNP P06730 EXPRESSION TAG SEQADV 8QM5 PHE A 33 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLN A 34 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY A 35 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ASN A 127 UNP P06730 ASP 127 CONFLICT SEQADV 8QM5 MET B 3 UNP P06730 INITIATING METHIONINE SEQADV 8QM5 HIS B 4 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS B 5 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS B 6 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS B 7 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS B 8 UNP P06730 EXPRESSION TAG SEQADV 8QM5 HIS B 9 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY B 10 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ALA B 11 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ARG B 12 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ILE B 13 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ILE B 14 UNP P06730 EXPRESSION TAG SEQADV 8QM5 TYR B 15 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ASP B 16 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ARG B 17 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ALA B 18 UNP P06730 EXPRESSION TAG SEQADV 8QM5 PHE B 19 UNP P06730 EXPRESSION TAG SEQADV 8QM5 LEU B 20 UNP P06730 EXPRESSION TAG SEQADV 8QM5 MET B 21 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ALA B 22 UNP P06730 EXPRESSION TAG SEQADV 8QM5 CYS B 23 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ARG B 24 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY B 25 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY B 26 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY B 27 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY B 28 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLU B 29 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ASN B 30 UNP P06730 EXPRESSION TAG SEQADV 8QM5 LEU B 31 UNP P06730 EXPRESSION TAG SEQADV 8QM5 TYR B 32 UNP P06730 EXPRESSION TAG SEQADV 8QM5 PHE B 33 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLN B 34 UNP P06730 EXPRESSION TAG SEQADV 8QM5 GLY B 35 UNP P06730 EXPRESSION TAG SEQADV 8QM5 ASN B 127 UNP P06730 ASP 127 CONFLICT SEQRES 1 A 215 MET HIS HIS HIS HIS HIS HIS GLY ALA ARG ILE ILE TYR SEQRES 2 A 215 ASP ARG ALA PHE LEU MET ALA CYS ARG GLY GLY GLY GLY SEQRES 3 A 215 GLU ASN LEU TYR PHE GLN GLY LYS HIS PRO LEU GLN ASN SEQRES 4 A 215 ARG TRP ALA LEU TRP PHE PHE LYS ASN ASP LYS SER LYS SEQRES 5 A 215 THR TRP GLN ALA ASN LEU ARG LEU ILE SER LYS PHE ASP SEQRES 6 A 215 THR VAL GLU ASP PHE TRP ALA LEU TYR ASN HIS ILE GLN SEQRES 7 A 215 LEU SER SER ASN LEU MET PRO GLY CYS ASP TYR SER LEU SEQRES 8 A 215 PHE LYS ASP GLY ILE GLU PRO MET TRP GLU ASP GLU LYS SEQRES 9 A 215 ASN LYS ARG GLY GLY ARG TRP LEU ILE THR LEU ASN LYS SEQRES 10 A 215 GLN GLN ARG ARG SER ASP LEU ASN ARG PHE TRP LEU GLU SEQRES 11 A 215 THR LEU LEU CYS LEU ILE GLY GLU SER PHE ASP ASP TYR SEQRES 12 A 215 SER ASP ASP VAL CYS GLY ALA VAL VAL ASN VAL ARG ALA SEQRES 13 A 215 LYS GLY ASP LYS ILE ALA ILE TRP THR THR GLU CYS GLU SEQRES 14 A 215 ASN ARG GLU ALA VAL THR HIS ILE GLY ARG VAL TYR LYS SEQRES 15 A 215 GLU ARG LEU GLY LEU PRO PRO LYS ILE VAL ILE GLY TYR SEQRES 16 A 215 GLN SER HIS ALA ASP THR ALA THR LYS SER GLY SER THR SEQRES 17 A 215 THR LYS ASN ARG PHE VAL VAL SEQRES 1 B 215 MET HIS HIS HIS HIS HIS HIS GLY ALA ARG ILE ILE TYR SEQRES 2 B 215 ASP ARG ALA PHE LEU MET ALA CYS ARG GLY GLY GLY GLY SEQRES 3 B 215 GLU ASN LEU TYR PHE GLN GLY LYS HIS PRO LEU GLN ASN SEQRES 4 B 215 ARG TRP ALA LEU TRP PHE PHE LYS ASN ASP LYS SER LYS SEQRES 5 B 215 THR TRP GLN ALA ASN LEU ARG LEU ILE SER LYS PHE ASP SEQRES 6 B 215 THR VAL GLU ASP PHE TRP ALA LEU TYR ASN HIS ILE GLN SEQRES 7 B 215 LEU SER SER ASN LEU MET PRO GLY CYS ASP TYR SER LEU SEQRES 8 B 215 PHE LYS ASP GLY ILE GLU PRO MET TRP GLU ASP GLU LYS SEQRES 9 B 215 ASN LYS ARG GLY GLY ARG TRP LEU ILE THR LEU ASN LYS SEQRES 10 B 215 GLN GLN ARG ARG SER ASP LEU ASN ARG PHE TRP LEU GLU SEQRES 11 B 215 THR LEU LEU CYS LEU ILE GLY GLU SER PHE ASP ASP TYR SEQRES 12 B 215 SER ASP ASP VAL CYS GLY ALA VAL VAL ASN VAL ARG ALA SEQRES 13 B 215 LYS GLY ASP LYS ILE ALA ILE TRP THR THR GLU CYS GLU SEQRES 14 B 215 ASN ARG GLU ALA VAL THR HIS ILE GLY ARG VAL TYR LYS SEQRES 15 B 215 GLU ARG LEU GLY LEU PRO PRO LYS ILE VAL ILE GLY TYR SEQRES 16 B 215 GLN SER HIS ALA ASP THR ALA THR LYS SER GLY SER THR SEQRES 17 B 215 THR LYS ASN ARG PHE VAL VAL HET W4U A 301 27 HET PGE B 301 10 HET W4U B 302 27 HETNAM W4U 1-(4-CHLOROPHENYL)CYCLOPENTANE-1-CARBOXYLIC ACID HETNAM PGE TRIETHYLENE GLYCOL FORMUL 3 W4U 2(C12 H13 CL O2) FORMUL 4 PGE C6 H14 O4 FORMUL 6 HOH *191(H2 O) HELIX 1 AA1 ASP A 16 CYS A 23 1 8 HELIX 2 AA2 ASN A 30 GLN A 34 5 5 HELIX 3 AA3 THR A 55 ASN A 59 1 5 HELIX 4 AA4 VAL A 69 SER A 82 1 14 HELIX 5 AA5 GLN A 120 ASP A 125 1 6 HELIX 6 AA6 ASP A 125 GLY A 139 1 15 HELIX 7 AA7 PHE A 142 ASP A 147 5 6 HELIX 8 AA8 ASN A 172 GLY A 188 1 17 HELIX 9 AA9 HIS A 200 THR A 205 1 6 HELIX 10 AB1 ASP B 16 CYS B 23 1 8 HELIX 11 AB2 TRP B 56 ALA B 58 5 3 HELIX 12 AB3 VAL B 69 SER B 83 1 15 HELIX 13 AB4 ASN B 84 MET B 86 5 3 HELIX 14 AB5 LYS B 119 GLY B 139 1 21 HELIX 15 AB6 PHE B 142 ASP B 147 5 6 HELIX 16 AB7 ASN B 172 GLY B 188 1 17 HELIX 17 AB8 HIS B 200 THR B 205 1 6 SHEET 1 AA1 8 LEU A 60 THR A 68 0 SHEET 2 AA1 8 PRO A 38 PHE A 48 -1 N PHE A 47 O ARG A 61 SHEET 3 AA1 8 ASP A 90 LYS A 95 -1 O SER A 92 N TRP A 46 SHEET 4 AA1 8 VAL A 149 ASN A 155 -1 O VAL A 154 N TYR A 91 SHEET 5 AA1 8 LYS A 162 THR A 167 -1 O TRP A 166 N GLY A 151 SHEET 6 AA1 8 GLY A 111 THR A 116 -1 N ILE A 115 O ILE A 163 SHEET 7 AA1 8 GLY A 196 SER A 199 -1 O GLN A 198 N ARG A 112 SHEET 8 AA1 8 PHE A 215 VAL A 216 -1 O PHE A 215 N TYR A 197 SHEET 1 AA2 8 LEU B 60 THR B 68 0 SHEET 2 AA2 8 PRO B 38 PHE B 48 -1 N LEU B 45 O SER B 64 SHEET 3 AA2 8 ASP B 90 LYS B 95 -1 O SER B 92 N TRP B 46 SHEET 4 AA2 8 VAL B 149 ASN B 155 -1 O CYS B 150 N LYS B 95 SHEET 5 AA2 8 GLY B 160 THR B 167 -1 O TRP B 166 N CYS B 150 SHEET 6 AA2 8 GLY B 111 ASN B 118 -1 N ILE B 115 O ILE B 163 SHEET 7 AA2 8 GLY B 196 SER B 199 -1 O GLN B 198 N ARG B 112 SHEET 8 AA2 8 PHE B 215 VAL B 216 -1 O PHE B 215 N TYR B 197 CRYST1 47.124 68.877 63.729 90.00 96.57 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021221 0.000000 0.002444 0.00000 SCALE2 0.000000 0.014519 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015795 0.00000